BioWorld - Wednesday, March 18, 2026

BioWorld Science

April 14, 1997

View Archived Issues

Pfizer reports new salt of known NMDA antagonist

Read More

PEP inhibitors from Chinoin

Read More

Fournier discloses bradykinin antagonists

Read More

Astra reveals novel opioid peptides

Read More

Novel heterocyclic 5-HT1B receptor antagonists disclosed by SKB

Read More

Antioxidants/sodium channel blockers from Takeda

Read More

University of Michigan researchers describe anti-HCMV agents

Read More

Orally active GH secretagogues reported by Lilly

Read More

Novartis describes small-molecule signal transduction inhibitors

Read More

Takeda reveals endothelin antagonists

Read More

Integrilin MAA withdrawn; companies await PURSUIT results

Read More

Tentative approval for Faulding's generic aciclovir for injection

Read More

Development of Auriculin suspended

Read More

Immunex's Enbrel demonstrates positive safety profile in RA patients

Read More

Scherer granted U.S. patent for ascorbic acid in softgel delivery system

Read More

First CFC-free inhaler launched in U.S.

Read More

Immunogene therapy for cancer enters clinical trials

Read More

Pharmacia & Upjohn introduces new GH delivery device

Read More

Positive results with Viracept combination therapy

Read More

FK-633 inhibits thrombosis and prevents restenosis in hamster model

Read More

Gilead's PMPA reduces HIV levels in clinical trials

Read More

Preclinical studies indicate potential of TAK-147 for AD

Read More

ABT-761 reduces bronchoconstriction and pulmonary inflammation in animals

Read More

Roberts' Agrylin available today in U.S.

Read More